Front Desk: 469-391-0070
Paliperidone Palmitate: Long-Acting Schizophrenia Treatment Guide
Key Points About Paliperidone Palmitate
Paliperidone palmitate is a long-acting injectable antipsychotic medication used to treat mental health conditions such as schizophrenia and schizoaffective disorder. Administered via injection, it helps manage symptoms like hallucinations, delusions, and mood swings. Its extended-release formulation eliminates the need for daily dosing, offering a more convenient treatment option for many patients. Always consult a healthcare provider before starting or adjusting your dose. If you’re considering this medication, schedule a telemedicine visit with one of our providers to discuss your treatment options.
Medication Names
US Brand Name: Invega Sustenna
Generic Name: Paliperidone palmitate
The generic name, “paliperidone palmitate,” refers to the active ingredient, while “Invega Sustenna” is the brand name assigned by the manufacturer.
Pharmacologic Category
Paliperidone palmitate belongs to the following categories:
- Second-generation antipsychotics (SGAs)
- Atypical antipsychotics
Paliperidone Palmitate Dosage
The dosage of paliperidone palmitate depends on the condition being treated. Always follow your healthcare provider’s instructions and never adjust your dose without professional guidance. If you have questions about your dosage, consider speaking with one of our telemedicine providers to create a personalized treatment plan.
Schizophrenia Treatment
Initial Dose: 234 mg on day 1, followed by 156 mg on day 8
Maintenance Dose: 39 mg to 234 mg once monthly
Duration: Long-term treatment as directed by your healthcare provider
Schizoaffective Disorder
Initial Dose: 234 mg on day 1, followed by 156 mg on day 8
Maintenance Dose: 78 mg to 234 mg once monthly
Duration: Long-term treatment as directed by your healthcare provider
Bipolar Disorder
Initial Dose: 234 mg on day 1, followed by 156 mg on day 8
Maintenance Dose: 78 mg to 234 mg once monthly
Duration: Long-term treatment as directed by your healthcare provider
Other Mental Health Conditions
Paliperidone palmitate is not FDA-approved for conditions such as depression, anxiety disorders, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), autism spectrum disorder, personality disorders, or psychotic disorders. However, in some cases, your healthcare provider may consider it as part of your treatment plan. Always consult your doctor before starting or changing any medication. If you’re exploring treatment options, schedule a telemedicine visit with one of our providers to discuss your symptoms and potential therapies.
Dosage Forms and Strengths
Paliperidone palmitate is available in the following injection strengths:
- 39 mg/0.25 mL
- 78 mg/0.5 mL
- 117 mg/0.75 mL
- 156 mg/1 mL
- 234 mg/1.5 mL
Administration Instructions
Paliperidone palmitate is administered as an intramuscular injection by a healthcare professional, typically in the upper arm or buttock. The initial doses are given one week apart, followed by monthly injections. Attending all scheduled appointments is crucial to ensure the medication’s effectiveness. If you miss a dose, contact your healthcare provider as soon as possible to reschedule. You can also book a telemedicine consultation to address any concerns or questions about your medication.
Paliperidone Side Effects and Adverse Reactions
As with all medications, paliperidone palmitate may cause side effects. While some are more common, others are rare but potentially serious. If you experience any of the following, consult your healthcare provider promptly:
Common Side Effects (1-10%)
- Drowsiness: Feeling unusually sleepy or fatigued
- Weight gain: Gradual increase in body weight
- Injection site reactions: Redness, swelling, or discomfort at the injection site
- Increased heart rate: Faster-than-normal heartbeat
Less Common Side Effects (0.1-1%)
- Restlessness: Difficulty sitting still or relaxing
- Muscle stiffness: Tight or rigid muscles
- Blurred vision: Trouble seeing clearly
Rare Side Effects (<0.1%)
- Tardive dyskinesia: Involuntary movements of the face, tongue, or other body parts
- Neuroleptic malignant syndrome: A rare but serious condition characterized by fever, muscle stiffness, and confusion
- Severe allergic reactions: Symptoms such as swelling, difficulty breathing, or rash. Seek immediate medical attention if this occurs
Contraindications for Paliperidone Palmitate
A contraindication refers to a specific situation in which a medication, such as Paliperidone palmitate, should not be used because it may pose significant risks. Below is a detailed overview of conditions where Paliperidone palmitate, a long-acting injectable antipsychotic, may not be appropriate:
Known hypersensitivity to paliperidone or risperidone: If you have previously experienced an allergic reaction to paliperidone or risperidone, you should avoid Paliperidone palmitate. Allergic reactions can range from mild symptoms, such as skin rashes, to severe and potentially life-threatening conditions like anaphylaxis.
Severe kidney impairment: Paliperidone is primarily processed and eliminated by the kidneys. If kidney function is significantly impaired, the medication can build up in the body, potentially leading to toxic effects.
History of neuroleptic malignant syndrome (NMS): NMS is a rare but serious reaction to antipsychotic medications, including Paliperidone palmitate. If you have experienced NMS in the past, using this medication may increase the likelihood of it occurring again.
Uncontrolled epilepsy: Paliperidone palmitate may lower the seizure threshold, making seizures more likely in individuals with epilepsy that is not well-managed.
Prolonged QT interval: This condition affects the heart’s electrical activity and can lead to abnormal heart rhythms. Paliperidone palmitate may further prolong the QT interval, increasing the risk of potentially dangerous arrhythmias.
If you have any of these conditions, it is essential to discuss them with your healthcare provider before starting Paliperidone palmitate. For personalized guidance, consider scheduling a telemedicine appointment with one of our providers. They can review your medical history and help determine the safest and most effective treatment plan for managing schizophrenia.
Drug-to-Drug Interactions with Paliperidone Palmitate
Paliperidone palmitate, an atypical antipsychotic, can interact with other medications, potentially increasing side effects or reducing its effectiveness. Below is a list of drugs that may interact with Paliperidone palmitate:
- Carbamazepine (Tegretol): This medication can lower the levels of Paliperidone in the bloodstream, reducing its effectiveness in treating schizophrenia.
- Quinidine (Quinidex): Quinidine may increase Paliperidone levels in the blood, which could heighten the risk of side effects.
- Fluoxetine (Prozac): Fluoxetine can raise Paliperidone levels, potentially causing side effects such as dizziness or excessive drowsiness.
- Paroxetine (Paxil): Similar to fluoxetine, paroxetine may increase Paliperidone levels in the body, leading to a higher likelihood of side effects.
- Levodopa (Sinemet): Paliperidone may reduce the effectiveness of levodopa, a medication commonly prescribed for Parkinson’s disease.
- Other antipsychotics: Combining Paliperidone palmitate with other antipsychotic medications can amplify the risk of side effects, including sedation and heart rhythm disturbances.
To minimize the risk of drug interactions, always inform your healthcare provider about all medications, supplements, and over-the-counter products you are currently taking. If you have concerns about potential interactions, our telemedicine providers are available to review your medication list and ensure your treatment plan is both safe and effective.
Paliperidone Palmitate and Pregnancy
Is it safe to take Paliperidone palmitate during pregnancy?
The safety of Paliperidone palmitate during pregnancy has not been fully established. While animal studies suggest there may be potential risks to the developing fetus, data on its effects in pregnant women remain limited. As a result, Paliperidone palmitate should only be used during pregnancy if the potential benefits outweigh the risks to both the mother and the baby.
If you are pregnant or planning to become pregnant, it is important to discuss your treatment options with your healthcare provider. They can help you carefully weigh the risks and benefits of continuing Paliperidone palmitate and work with you to develop a treatment plan that prioritizes both your mental health and your baby’s well-being.
Paliperidone Palmitate While Breastfeeding
Is it safe to take Paliperidone palmitate while breastfeeding?
Paliperidone, the active ingredient in Paliperidone palmitate, can pass into breast milk and may have an impact on a nursing infant. The decision to use Paliperidone palmitate while breastfeeding should be made after a thorough evaluation of the potential risks and benefits.
If you are currently breastfeeding or plan to breastfeed, consult your healthcare provider to determine whether Paliperidone palmitate is the most appropriate choice for your situation. Your provider may recommend alternative treatments or suggest monitoring your baby closely for any potential side effects if you decide to continue using the medication.
Estimated Cost of Paliperidone Palmitate
The cost of Paliperidone palmitate, a long-acting injectable antipsychotic, can vary depending on the dosage and your location. Without insurance, the price for a 30-day supply typically ranges between $1,500 and $2,000 when using a GoodRX coupon. For the most accurate and up-to-date pricing, consider checking GoodRX or similar discount programs. Additionally, speak with your healthcare provider about financial assistance programs that may be available to help manage the cost.
Possible Alternatives to Paliperidone Palmitate
If Paliperidone palmitate is not the right fit for you, there are several alternative treatments available, depending on your specific condition. Below are some commonly recommended options:
Schizophrenia: Alternatives include aripiprazole (Abilify), olanzapine (Zyprexa), and non-medication approaches such as stress management techniques and cognitive behavioral therapy (CBT).
Schizoaffective Disorder: Treatment options may include lithium, valproate (Depakote), or other mood stabilizers. Psychotherapy and regular physical activity can also play a key role in managing symptoms.
Bipolar Disorder: Common alternatives include mood stabilizers like lithium or lamotrigine (Lamictal). Establishing a consistent sleep routine and minimizing stress can further support symptom management.
Depression: Selective serotonin reuptake inhibitors (SSRIs), such as sertraline (Zoloft) or fluoxetine (Prozac), are often prescribed. Incorporating regular exercise and mindfulness practices may also help improve mood.
Anxiety Disorders: SSRIs or benzodiazepines, such as lorazepam (Ativan), are frequently used. Cognitive behavioral therapy and relaxation techniques, like deep breathing or meditation, can also be effective.
Obsessive-Compulsive Disorder (OCD): SSRIs, including fluvoxamine (Luvox) or clomipramine (Anafranil), are common alternatives. Exposure and response prevention therapy is a highly effective non-medication treatment option.
Post-Traumatic Stress Disorder (PTSD): SSRIs, such as paroxetine (Paxil) or sertraline (Zoloft), are often recommended. Trauma-focused therapy is considered a cornerstone of treatment for PTSD.
Autism Spectrum Disorder: Medications like risperidone (Risperdal) or aripiprazole (Abilify) may help manage irritability. Behavioral therapy and maintaining structured routines can also be beneficial.
Personality Disorders: Psychotherapy is the primary treatment approach. Depending on the specific symptoms, mood stabilizers or antidepressants may also be prescribed.
Psychotic Disorders: Alternatives include aripiprazole (Abilify), quetiapine (Seroquel), or olanzapine (Zyprexa). Psychosocial interventions and family therapy can provide additional support.
Before making any changes to your treatment plan, it’s essential to consult your healthcare provider. If you’re exploring alternatives to Paliperidone palmitate, our telemedicine providers are here to help guide you through your options and find the best solution for your needs.
Recent Updates on Paliperidone Palmitate Research
Recent studies on Paliperidone palmitate, an atypical antipsychotic medication, continue to underscore its long-term effectiveness and safety in treating schizophrenia and schizoaffective disorder. A 2022 study demonstrated that Paliperidone palmitate, when administered as a long-acting injectable, significantly reduced the risk of relapse in patients with schizophrenia compared to oral antipsychotics. Additionally, ongoing research is exploring its potential use in managing other conditions, such as bipolar disorder and autism spectrum disorder. However, further studies are needed before it can be widely recommended for these additional indications.
As research progresses, staying informed about new findings is vital. If you have questions about the latest studies or how they might influence your treatment plan, consider scheduling a consultation with one of our telemedicine providers for personalized guidance.
